Agreement - January 24, 2024
Offspring Biosciences enters partership with Flagship Biosciences
Swedish pre-clinical biomarker assay company Offspring Biosciences and US spatial biology and biomarker analytics company Flagship Biosciences have announced a strategic partnership. The partnership aims to further advance precision drug development with a complete biomarker offering from discovery to companion diagnostics development, the companies state. “Together, Flagship Biosciences and Offspring Biosciences will provide a seamless […]
Acquisition - January 16, 2024
Key2Compliance acquired by GBA Group
With the acquisition GBA Group is expanding its range of consulting and training services for the medical device, In Vitro Diagnostics (IVD), and pharmaceutical industry. “As we have set ourselves the goal of being a broad-based service provider for medical devices, Key2Compliance, with its consulting and training services and expertise, is a perfect fit for […]
Intellectual Property - January 12, 2024
Capitainer secures three US patents
Capitainer has announced the grant of three US patents for their soon to be launched plasma/serum separation device. “These patents reinforce our strategic position, facilitating Capitainer’s expansion in the US market. The recognition from the United States Patent Office is a testament to the technological advancements we’ve achieved. This enables us to extend our advanced […]
Collaboration - December 20, 2023
Elekta and Bristol Myers Squibb enter partnership
Elekta has announced a pilot collaboration with Bristol Myers Squibb to develop a digital solution for patients with melanoma. “We are thrilled to collaborate with Bristol Myers Squibb to potentially advance the use of digital health interventions, such as in the treatment of melanoma,” says Anish Patankar, SVP & Head of Business Line Software at […]
Acquisition - December 11, 2023
Mentice enters agreement to acquire all substantial assets from Biomodex
The global Biomodex business reached a total turnover of EUR 2.2 million in 2022. Biomodex specializes in biorealistic 3D printing and flow systems for interventional procedures, with a platform geared towards clinical use and patient-specific simulation. As part of the acquisition, Mentice will also retain key employees of Biomodex. “Biomodex is truly a quality product […]
Collaboration - December 7, 2023
Camallergy and OnDosis enter strategic collaboration
The partnership is set to transform the way food allergies (including peanut allergy) are treated and will combine Camallergy’s therapies with OnDosis’ Dosage Manager device technology. The drug-device combination aims to address the challenges physicians face in offering oral immunotherapy, making the treatment more accessible for patients, the company states. Oral immunotherapy (OIT) is a […]
